← Back to Clinical Trials
Recruiting NCT06854744

Zinc Oxide Ozonated Olive Oil in LSTR

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Pulpitis - Irreversible
Sponsor Tanta University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 4 Years
Max Age 7 Years
Start Date 2024-01-15
Completion 2025-02
Interventions
lesion sterlization and tissue repairZinc Oxide Ozonated OilModified Triple Antibiotic Paste

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study will be carried out to evaluate and compare the clinical and radiographic effect of zinc oxide-ozonated olive oil (ZnO-OO) versus Modified Triple Antibiotic Paste (MTAP) as a Lesion Sterilization and Tissue Repair Technique in Primary Molars

Eligibility Criteria

Inclusion Criteria: 1- Cooperative patients in the age group of (4-7) years with no associated systemic illness. 2- Bilateral mandibular primary molars showing signs and symptoms of pulp necrosis or chronic pulp infection with/without hemorrhage, suppuration, or purulence. 3- Spontaneous pain or tenderness to percussion. 4- Presence of chronic apical abscess, sinus tract, or grade I mobility. 5-The tooth should be restorable. 6- Radiographic characteristics are: 1. Widening of Periodontal ligament space. 2. Radicular involvement. 3. Furcation involvement less than or equal to half of the shortest root in the vertical dimension \- Exclusion Criteria: Exclusion criteria : 1. Physiologic root resorption is more than one-third of its length. 2. Excessive internal resorption. 3. Non-restorable teeth exhibiting greater than grade I mobility. 4. Perforation into the bifurcation. 5. Any underlying pathological lesion. 6. Any previous history of allergy to the antibiotics used in the study. -

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}